An open-label, multi-centre, post-marketing study to assess the efficacy and safety of a plasma-derived VWF/FVIII concentrate in patients with von Willebrand disease.
Wolfgang MiesbachSusan HalimehHelen PlatokoukiMaria Podolak-DawidziakJoanna ZdziarskaBartosz KorczowskiPratima ChowdarySteve AustinCarolyn MillarJayanthi AlameluTobias RogoschIngrid Pabinger-FaschingPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Keyphrases